3Couillinl , pol S, Mancini M, et al. Specific vaccine therapy in chronic hepatitis B induction of T cell proliferative response specific for envelope antigens.J Infect Dis .1999, 180 (1): 15.
4Nagafuehi S, Kashivagi S, Hayashi S, et al. Delayed type hypersensitivity (DTH) skin reaction to hepatitis B surface antigen (HBsAg) in patients with type B acute and chronic hepatitis. Clin Exp Immunol, 1985, 61:569.
二级参考文献9
1Senturk H, Tahazk F, Akdogan M, et al. Therapeutic vaccination in chronic hepatitis B. J Gastroenterol Hepatol, 2002,17(1):72 - 76.
2Dahmen A, Herzog - Hauff S, Bocher WO, et al. Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin - 2 in patients with chronic hepatitis B.J Med Virol, 2002, 66(4):452-460.
3Akbar SMF, Kajino K, Tanimoto K, et al.Placebo - controlled trials of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol, 1997, 26:131 -137.
4Pol S, Nalpas B, Driss F, et al. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B. J Hepatol. 2001,34:917 - 921.
